DEPINAR Drug Patent Profile
✉ Email this page to a colleague
When do Depinar patents expire, and when can generic versions of Depinar launch?
Depinar is a drug marketed by Armour Pharm and is included in one NDA.
The generic ingredient in DEPINAR is cyanocobalamin; tannic acid; zinc acetate. There are nine drug master file entries for this compound. Additional details are available on the cyanocobalamin; tannic acid; zinc acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEPINAR?
- What are the global sales for DEPINAR?
- What is Average Wholesale Price for DEPINAR?
Summary for DEPINAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 32 |
| DailyMed Link: | DEPINAR at DailyMed |
US Patents and Regulatory Information for DEPINAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Armour Pharm | DEPINAR | cyanocobalamin; tannic acid; zinc acetate | INJECTABLE;INJECTION | 011208-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
